Question

I am a breastfeeding mother and i want to know if it is safe to use 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide? Is 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide safe for nursing mother and child? Does 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide extracts into breast milk? Does 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide has any long term or short term side effects on infants? Can 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide influence milk supply or can 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide decrease milk supply in lactating mothers?

4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide lactation summary

4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide usage has low risk in breastfeeding
  • DrLact safety Score for 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide usage in lactation

Sulfonilurea drugs stimulate secretion of endogen insulin. Oral anti-diabetic drugs are useless for treatment of diabetes type 1. For diabetes type 2, diet and exercise are advisable. Breastfeeding helps to lower glucemia level. See section on Maternal diabetes mellitus

Answer by DrLact: About 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide usage in lactation

Limited data indicate that amounts of 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide in breastmilk are unlikely to affect a breastfed infant. Short-acting drugs are generally preferred while breastfeeding a neonate to avoid drug accumulation. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with hypoglycemic agents.[1][2]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.